Articles les plus consultés

  • Les futures sur cac belle glissade < vix pas bon + 3%
        francis 13 Version sans publicité Marchés   Actualités   Analyses   Crypto   Fonds   Graphiques   Technique   Brokers   Outils   Portefe...
  • Nouvelles applications de médicaments avec des documents de soutien
    6% Hydroxyethyl Starch 130 / 0.4 in 0.9% Injection de chlorure de sodium (Voluven 500 mL freeflex flexible en plastique intraveineuse solut...
  • pre-market
    Top Gaining Stocks % Chg Dernier Symb Compagnie Le volume 16,22% 2.15 SRNE Sorrento Therapeut 7030 10,92% 2,64 CIE Cobalt Inte...
  • pre-market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Iridium   14.95 + 39.07% 0,60K Mondialisation de l'Inde.   0,4800 + 18,52% 1,80K...
  • pre-market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Oracle Corporation   51.30 + 10,73% 58.90K Staples Inc   9.25 + 6,81% 12,31K Delcat...
  • les élus
    Citoyens_Français ‏   @citoyenneFrance     8 juin Plus Attali : « Les élus n’ont plus de pouvoir et voici votre avenir » - Effr......
  • pre-market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Lipocine In   5.32 + 32,34% 38.64K Enphase Energy Inc   0,938 + 17,57% 10,37K Delca...
  • pre_market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Delcath   0.1230 + 24,24% 196,67K Neos Therapeutics I.   10.50 +16.67% 34.36K Enpha...
  • bonjour.. approbations
    28 juin 2017 Nom du médicament et  numéro de demande Ingrédient actif Formulaire de posologie / itinéraire Soumission Compagnie ...
  • $ pré-market
    Plus fortes hausses en préouverture Nom Dernier Var.% Vol. DragonWave Inc   1,3900 +25,23% 3,55K Alibaba   139,95 +11,35% 1,40M MoSys...

mardi 8 mai 2018

Cyclacel Pharmaceuticals to Release First Quarter 2018 Financial Results

Cyclacel Pharmaceuticals to Release First Quarter 2018 Financial Results
Posted by at Aucun commentaire:

MediciNova Announces Plans to Collaborate with UCLA Researchers in Grant-Funded Clinical Trial of MN-166 (ibudilast) in Alcohol Use Disorder and Withdrawal

MediciNova Announces Plans to Collaborate with UCLA Researchers in Grant-Funded Clinical Trial of MN-166 (ibudilast) in Alcohol Use Disorder and Withdrawal
Posted by at Aucun commentaire:

lundi 7 mai 2018

PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly Dividend of $0.25 per Share

PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly Dividend of $0.25 per Share
Posted by at Aucun commentaire:

Nymox Announces Relocation of Company Headquarters to Switzerland

Nymox Announces Relocation of Company Headquarters to Switzerland
Posted by at Aucun commentaire:

Ambu A/S: Interim report for Q2 2017/18 and for the half-year (1 October 2017- 31 March 2018)

Ambu A/S: Interim report for Q2 2017/18 and for the half-year (1 October 2017- 31 March 2018)
Posted by at Aucun commentaire:

OSE Immunotherapeutics Presents New Data on OSE-127 at the American Association of Immunologists (AAI) Annual Meeting May 4-8 2018 in Austin, Texas

OSE Immunotherapeutics Presents New Data on OSE-127 at the American Association of Immunologists (AAI) Annual Meeting May 4-8 2018 in Austin, Texas
Posted by at Aucun commentaire:

BeiGene to Present at the Deutsche Bank 43rd Annual Health Care Conference

BeiGene to Present at the Deutsche Bank 43rd Annual Health Care Conference
Posted by at Aucun commentaire:
Inscription à : Commentaires (Atom)